Hepatic Veno-Occlusive Disease clinical trials at UCSF

1 research study open to eligible people

Hepatic veno-occlusive disease is a condition where small veins in the liver are blocked. UCSF is conducting a study using ultrasound to predict if this disease will develop. The trial aims to find a threshold to help identify the disease early.

Showing trials for

  • Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome

    open to eligible people ages 1 month to 99 years

    To perform an receiver operating characteristic (ROC) analysis, define a threshold and quantify the sensitivity and specificity of US SWE for risk stratification of patients into three categories as defined by the European Bone Marrow Transplant (EBMT) adult and pediatric criteria: no sinusoidal obstruction syndrome (SOS), mild to moderate SOS, and severe to very severe SOS. Secondarily, the investigators would also like to quantify the temporal relationship between US SWE changes and SOS diagnosis according to various clinical criteria (Modified Seattle, Baltimore, EBMT consortium).

    San Francisco, California and other locations

Our lead scientists for Hepatic Veno-Occlusive Disease research studies include .

Last updated: